XIFR:NYSEXPLR Infrastructure, LP Analysis
Data as of 2026-09-01 - not real-time
$12.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
XPLR Infrastructure, LP is priced at $12.00, and its moving averages give no clean directional read — the structure is neutral. With RSI at 56.6 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near $10.97 and resistance around $12.02.
On valuation the read is undervalued — earnings multiple of 17.1 versus a 19.2 sector average, below the peer group. Revenue is growing at 6.1% on a 5.2% profit margin.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 42.2%, a beta of 1.17 and a maximum drawdown of 20.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
On valuation the read is undervalued — earnings multiple of 17.1 versus a 19.2 sector average, below the peer group. Revenue is growing at 6.1% on a 5.2% profit margin.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 42.2%, a beta of 1.17 and a maximum drawdown of 20.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
XPLR Infrastructure XIFR delivered earnings and revenue surprises of +180.XPLR Infrastructure LP XIFR reports robust EBITDA and cash flow projections for 2026, despite challenges from increased...XPLR Infrastructure, LP NYSE: XIFR has posted its second-quarter 2026 financial results in a news release available on...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 10.73
- MACD momentum is positive
- 30-day volatility of 42.2%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 17.1 versus sector average of 19.2
- Trading above the 200-day average of 10.73
- 30-day volatility of 42.2%
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 17.1 versus sector average of 19.2
- Negative return on equity of -1.6%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth6.10%
Profit Margin5.16%
P/E Ratio17.1
ROE-1.61%
ROA0.01%
Debt/Equity56.83
P/B Ratio0.4
Op. Cash Flow$645.0M
Free Cash Flow$-777875008
Industry P/E19.2
Technical Analysis
TrendNeutral
RSI56.6
Support$10.97
Resistance$12.02
MA 20$11.56
MA 50$11.89
MA 200$10.73
MACDBullish
VolumeStable
Fear & Greed Index94.79
Valuation
Fair Value$20.39
Target Price$12.23
Upside/Downside1.89%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.17
Volatility42.15%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.